Gregory Everson
Company: HepQuant
Job title: Managing Director & CEO
Seminars:
Progressing towards a Sensitive and Reliable Endpoint for Treatment Efficacy 11:00 am
• New Data from Clinical Trials (response to new pharma therapy, reproducibility, progression to decomp in cirrhosis, portal hypertension) • Pivotal Study and Regulatory Progress • Anticipated Timelines for Clinical Trial and Commercial Scale-upRead more
day: Day 1 Stream 3 AM